{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:55:48Z","timestamp":1790128548820,"version":"4.0.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Antibiot"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1038\/s41429-025-00883-y","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T09:48:49Z","timestamp":1763718529000},"page":"67-73","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Thiofrenomycins, new kalafungin-type pyranonaphthoquinone skeleton with sulfide linkage from Streptomyces sp. MM863L-181F9"],"prefix":"10.1038","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0864-4954","authenticated-orcid":false,"given":"Tomoyuki","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6893-0050","authenticated-orcid":false,"given":"Yoshimasa","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Umekita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rie","family":"Arisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5900-2113","authenticated-orcid":false,"given":"Hideyuki","family":"Muramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chigusa","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-3881","authenticated-orcid":false,"given":"Isao","family":"Momose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shimuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8190-0195","authenticated-orcid":false,"given":"Ryuichi","family":"Sawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1562-6685","authenticated-orcid":false,"given":"Masayuki","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"883_CR1","unstructured":"WHO: Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. https:\/\/www.who.int\/publications\/i\/item\/9789240027077."},{"key":"883_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41572-019-0128-6","volume":"5","author":"M Unemo","year":"2019","unstructured":"Unemo M, et al. Gonorrhoea. Nat Rev Dis Prim. 2019;5:79.","journal-title":"Nat Rev Dis Prim"},{"key":"883_CR3","unstructured":"WHO: Treatment of Neisseria gonorrhoeae. https:\/\/iris.who.int\/bitstream\/handle\/10665\/246114\/9789241549691-eng.pdf."},{"key":"883_CR4","doi-asserted-by":"publisher","first-page":"e627","DOI":"10.1016\/S2666-5247(21)00171-3","volume":"2","author":"M Unemo","year":"2021","unstructured":"Unemo M, et al. WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017\u201318: a retrospective observational study. Lancet Microbe. 2021;2:e627\u2013636.","journal-title":"Lancet Microbe"},{"key":"883_CR5","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3201\/eid3008.240139","volume":"30","author":"L Xiu","year":"2024","unstructured":"Xiu L, Zhang L, Peng J. Surge in ceftriaxone-resistant Neisseria gonorrhoeae FC428-like strains, Asia-Pacific region, 2015\u22122022. Emerg Infect Dis. 2024;30:1683\u20136.","journal-title":"Emerg Infect Dis"},{"key":"883_CR6","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/jac\/dkae369","volume":"79","author":"H Fifer","year":"2024","unstructured":"Fifer H, Doumith M, Rubinstein L, Mitchell L, Wallis M. Ceftriaxone-resistant Neisseria gonorrhoeae detected in England, 2015\u201324: an observational analysis. J Antimicrob Chemother. 2024;79:3332\u20139.","journal-title":"J Antimicrob Chemother"},{"key":"883_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00927-24","volume":"68","author":"JH Melendez","year":"2024","unstructured":"Melendez JH, et al. Local emergence and global evolution of Neisseria gonorrhoeae with high-level resistance to azithromycin. Antimicrob Agents Chemother. 2024;68:e0092724.","journal-title":"Antimicrob Agents Chemother"},{"key":"883_CR8","doi-asserted-by":"publisher","first-page":"1800323","DOI":"10.2807\/1560-7917.ES.2018.23.27.1800323","volume":"23","author":"DW Eyre","year":"2018","unstructured":"Eyre DW, et al. Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Eur Surveill. 2018;23:1800323.","journal-title":"Eur Surveill"},{"key":"883_CR9","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.3201\/eid3009.240557","volume":"30","author":"F Cam\u00e9l\u00e9na","year":"2024","unstructured":"Cam\u00e9l\u00e9na F, et al. Emergence of extensively drug-resistant Neisseria gonorrhoeae, France, 2023. Emerg Infect Dis. 2024;30:1903\u20136.","journal-title":"Emerg Infect Dis"},{"key":"883_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0140-6736(23)02196-7","volume":"403","author":"F Wagenlehner","year":"2024","unstructured":"Wagenlehner F, et al. Oral gepotidacin versus nitrofurantoin in patients with uncomplicated urinary tract infection (EAGLE-2 and EAGLE-3): two randomised, controlled, double-blind, double-dummy, phase 3, non-inferiority trials. Lancet. 2024;403:741\u201355.","journal-title":"Lancet"},{"key":"883_CR11","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/S0140-6736(25)00628-2","volume":"405","author":"JDC Ross","year":"2025","unstructured":"Ross JDC, et al. Oral gepotidacin for the treatment of uncomplicated urogenital gonorrhoea (EAGLE-1): a phase 3 randomised, open-label, non-inferiority, multicentre study. Lancet. 2025;405:1608\u201320.","journal-title":"Lancet"},{"key":"883_CR12","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1021\/np400231r","volume":"76","author":"XC Wang","year":"2013","unstructured":"Wang XC, et al. Frenolicins C-G, Pyranonaphthoquinones from sp RM-4-15. J Nat Prod. 2013;76:1441\u20137.","journal-title":"J Nat Prod"},{"key":"883_CR13","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7164\/antibiotics.53.687","volume":"53","author":"M Tsukamoto","year":"2000","unstructured":"Tsukamoto M, et al. New cytotoxic agents, BE-52440A and B, produced by a streptomycete. J Antibiotics. 2000;53:687\u201393.","journal-title":"J Antibiotics"},{"key":"883_CR14","doi-asserted-by":"publisher","first-page":"8018","DOI":"10.1016\/j.tetlet.2007.09.039","volume":"48","author":"K Tatsuta","year":"2007","unstructured":"Tatsuta K, Suzuki Y, Toriumi T, Furuya Y, Hosokawa S. The first total synthesis and structural determination of (+)-BE-52440A. Tetrahedron Lett. 2007;48:8018\u201321.","journal-title":"Tetrahedron Lett"},{"key":"883_CR15","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1021\/np400742p","volume":"77","author":"DK Derewacz","year":"2014","unstructured":"Derewacz DK, et al. Structure and Stereochemical Determination of Hypogeamicins from a Cave-Derived Actinomycete. J Nat Prod. 2014;77:1759\u201363.","journal-title":"J Nat Prod"},{"key":"883_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2025.114404","volume":"233","author":"X Ding","year":"2025","unstructured":"Ding X, et al. Crepidamycins A-E, pyranonaphthoquinones from endophytic Streptomyces sp. MG-F-1 of Dendrobium crepidatum by the co-culture strategy. Phytochem. 2025;233:114404.","journal-title":"Phytochem"},{"key":"883_CR17","doi-asserted-by":"publisher","first-page":"4339","DOI":"10.1128\/AAC.00504-16","volume":"60","author":"S Nakayama","year":"2016","unstructured":"Nakayama S, et al. New ceftriaxone- and multidrug-resistant Neisseria gonorrhoeae strain with a novel mosaic penA gene isolated in Japan. Antimicrob Agents Chemother. 2016;60:4339\u201341.","journal-title":"Antimicrob Agents Chemother"},{"key":"883_CR18","volume":"4","author":"K Yahara","year":"2018","unstructured":"Yahara K, et al. Genomic surveillance of Neisseria gonorrhoeae to investigate the distribution and evolution of antimicrobial-resistance determinants and lineages. Microb Genomics. 2018;4:e000205.","journal-title":"Microb Genomics"},{"key":"883_CR19","doi-asserted-by":"publisher","first-page":"2468","DOI":"10.1128\/AAC.43.10.2468","volume":"43","author":"L Zarantonelli","year":"1999","unstructured":"Zarantonelli L, Borthagaray G, Lee EH, Shafer WM. Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations. Antimicrob Agents Chemother. 1999;43:2468\u201372.","journal-title":"Antimicrob Agents Chemother"},{"key":"883_CR20","doi-asserted-by":"publisher","first-page":"5619","DOI":"10.1128\/JB.184.20.5619-5624.2002","volume":"184","author":"WL Veal","year":"2002","unstructured":"Veal WL, Nicholas RA, Shafer WM. Overexpression of the MtrC- MtrD-MtrE efflux pump due to an mtrR mutation is required for chromosomally mediated penicillin resistance in Neisseria gonorrhoeae. J Bacteriol. 2002;184:5619\u201324.","journal-title":"J Bacteriol"},{"key":"883_CR21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1039\/C6NP00080K","volume":"34","author":"BJ Naysmith","year":"2017","unstructured":"Naysmith BJ, Hume PA, Sperry J, Brimble MA. Pyranonaphthoquinones \u2013 isolation, biology and synthesis: an update. Nat Prod Rep. 2017;34:25\u201361.","journal-title":"Nat Prod Rep"},{"key":"883_CR22","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.chembiol.2018.11.013","volume":"26","author":"Q Ye","year":"2019","unstructured":"Ye Q, et al. Frenolicin B targets peroxiredoxin 1 and glutaredoxin 3 to trigger ROS\/4E-BPl-mediated antitumor effects. Cell Chem Biol. 2019;26:366\u201377.","journal-title":"Cell Chem Biol"}],"container-title":["The Journal of Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00883-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00883-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T23:02:37Z","timestamp":1769468557000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41429-025-00883-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["883"],"URL":"https:\/\/doi.org\/10.1038\/s41429-025-00883-y","relation":{},"ISSN":["0021-8820","1881-1469"],"issn-type":[{"value":"0021-8820","type":"print"},{"value":"1881-1469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"2 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}